Probing voltage sensing domain of KCNQ2 channel as a potential target to combat epilepsy: a comparative study.

about

Probing voltage sensing domain of KCNQ2 channel as a potential target to combat epilepsy: a comparative study.

Item

http://www.wikidata.org/entity/Q50252143

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Probing voltage sensing domain ...... epilepsy: a comparative study.

@en

Probing voltage sensing domain ...... epilepsy: a comparative study.

@nl

type

Item

label

Probing voltage sensing domain ...... epilepsy: a comparative study.

@en

Probing voltage sensing domain ...... epilepsy: a comparative study.

@nl

prefLabel

Probing voltage sensing domain ...... epilepsy: a comparative study.

@en

Probing voltage sensing domain ...... epilepsy: a comparative study.

@nl

P1476

Probing voltage sensing domain ...... epilepsy: a comparative study

@en

P2093

Bhanwar Singh Choudhary

http://www.w3.org/2001/XMLSchema#string

Manish Sharma

http://www.w3.org/2001/XMLSchema#string

Pakhuri Mehta

http://www.w3.org/2001/XMLSchema#string

Ruchi Malik

http://www.w3.org/2001/XMLSchema#string

P2860

Hit identification and optimization in virtual screening: practical recommendations based on a critical literature analysis

Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor

ChEMBL: a large-scale bioactivity database for drug discovery

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy

Assessment of the health effects of chemicals in humans: I. QSAR estimation of the maximum recommended therapeutic dose (MRTD) and no effect level (NOEL) of organic chemicals based on clinical trial data.

Integrating structure-based and ligand-based approaches for computational drug design.

Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier

Isoform-specific prolongation of Kv7 (KCNQ) potassium channel opening mediated by new molecular determinants for drug-channel interactions

P304

578-589

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10799893.2017.1369122

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shubham Srivastava

P577

2017-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28856943

http://www.w3.org/2001/XMLSchema#string